![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, October 03, 2000 6:02:31 AM
We have developed unique and comprehensive SNP databases through the use of proprietary
data mining techniques. Our work has so far resulted in two distinct databases, one for cancer
predisposition screening and the other for drug interactivity screening. Our databases are fully
annotated, and contain relevant LocusLink, Medline, UniGene, Entrez, and PubMed
information. What makes our database even more unique is that it contains flanking sequence
5’ and 3’ for each target SNP which enables rapid application to microchip based screening
platforms. The data and annotation that we have compiled does not currently exist in any NCBI
or other public database, and we currently enjoy their exclusive use.
http://www.dnaprint.com./index.cfm?fuseaction=content&id=27
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM